¡Ya estamos en ! Descubre más
icono de BEATW

Heartbeam Warrant
BEATW

Dejó de cotizar

BEATW dejó de cotizar en bolsa el 13 de noviembre de 2026.

 

Acerca de: HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Empleados: 16

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 0%
Neutral 0%
Negativo 0%
Gráficos de precios implementados con Lightweight Charts™